Terry Moore

Introduction

Dr. Terry Moore  (Google Scholar - LinkedIn - ResearchGate - UIC Faculty Page)

Dr. Moore's collaborative research program focuses on making and studying new drug-like molecules that target an important, yet understudied, group of drug targets: transcription factors. Controlling and modulating gene expression with small molecules and peptides has the potential to pave the way for new therapeutics to treat important biomedical problems, like chronic wound healing and many types of cancer. As a result of this work, he was named the 2017 UIC Rising Star Researcher of the Year in the Basic Life Sciences. This success as an independent investigator is consonant with his training with two of the world’s most well-respected academic medicinal chemists: John Katzenellenbogen and Dennis Liotta. As a Ph.D. student with John Katzenellenbogen at UIUC, Dr. Moore gained experience with high-throughput screens and developing structure-activity relationships arising from small molecules identified from those screens. As a postdoctoral fellow with Dennis Liotta at Emory University, he developed an expertise in small molecule hit-to-lead optimization, with a particular emphasis on simultaneously enhancing potency, physicochemical and pharmaceutical properties of preclinical agents. Since arriving at UIC, he has established a productive research team to study several transcription factors, including estrogen receptor and NRF2. (Photo by UIC - Jenny Fontaine)